Affymax Stock Performance
| AFFY Stock | USD 0.0008 0.00 0.00% |
Affymax holds a performance score of 10 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 10.93, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Affymax will likely underperform. Use Affymax information ratio and the relationship between the maximum drawdown and day typical price , to analyze future returns on Affymax.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Affymax are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent technical and fundamental indicators, Affymax showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Affymax |
Affymax Relative Risk vs. Return Landscape
If you would invest 0.09 in Affymax on November 7, 2025 and sell it today you would lose (0.01) from holding Affymax or give up 11.11% of portfolio value over 90 days. Affymax is currently generating 5.8234% in daily expected returns and assumes 42.7513% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Affymax, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Affymax Target Price Odds to finish over Current Price
The tendency of Affymax Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.0008 | 90 days | 0.0008 | about 66.55 |
Based on a normal probability distribution, the odds of Affymax to move above the current price in 90 days from now is about 66.55 (This Affymax probability density function shows the probability of Affymax Pink Sheet to fall within a particular range of prices over 90 days) .
Affymax Price Density |
| Price |
Predictive Modules for Affymax
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Affymax. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Affymax Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Affymax is not an exception. The market had few large corrections towards the Affymax's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Affymax, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Affymax within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 4.86 | |
β | Beta against Dow Jones | 10.93 | |
σ | Overall volatility | 0.0006 | |
Ir | Information ratio | 0.13 |
Affymax Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Affymax for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Affymax can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Affymax is way too risky over 90 days horizon | |
| Affymax has some characteristics of a very speculative penny stock | |
| Affymax appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 1.37 M. Net Loss for the year was (14.42 M) with loss before overhead, payroll, taxes, and interest of (10.49 M). | |
| Affymax currently holds about 3.4 M in cash with (67.34 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.09, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Affymax Fundamentals Growth
Affymax Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Affymax, and Affymax fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Affymax Pink Sheet performance.
| Return On Equity | 1.12 | |||
| Return On Asset | -2.29 | |||
| Profit Margin | 73.00 % | |||
| Current Valuation | (512.26 K) | |||
| Shares Outstanding | 37.49 M | |||
| Price To Earning | 0.08 X | |||
| Price To Book | 0.56 X | |||
| Price To Sales | 65.27 X | |||
| Revenue | 1.37 M | |||
| EBITDA | (47.65 M) | |||
| Cash And Equivalents | 3.4 M | |||
| Cash Per Share | 0.09 X | |||
| Debt To Equity | 1.07 % | |||
| Book Value Per Share | 0.14 X | |||
| Cash Flow From Operations | (67.34 M) | |||
| Earnings Per Share | 0.01 X | |||
| Total Asset | 7.44 M | |||
| Retained Earnings | (692.53 M) | |||
| Current Asset | 6.32 M | |||
| Current Liabilities | 8.87 M | |||
About Affymax Performance
Evaluating Affymax's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Affymax has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Affymax has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York. Affymax operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people.Things to note about Affymax performance evaluation
Checking the ongoing alerts about Affymax for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Affymax help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Affymax is way too risky over 90 days horizon | |
| Affymax has some characteristics of a very speculative penny stock | |
| Affymax appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 1.37 M. Net Loss for the year was (14.42 M) with loss before overhead, payroll, taxes, and interest of (10.49 M). | |
| Affymax currently holds about 3.4 M in cash with (67.34 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.09, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Affymax's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Affymax's stock is overvalued or undervalued compared to its peers.
- Examining Affymax's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Affymax's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Affymax's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Affymax's pink sheet. These opinions can provide insight into Affymax's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Affymax Pink Sheet Analysis
When running Affymax's price analysis, check to measure Affymax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Affymax is operating at the current time. Most of Affymax's value examination focuses on studying past and present price action to predict the probability of Affymax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Affymax's price. Additionally, you may evaluate how the addition of Affymax to your portfolios can decrease your overall portfolio volatility.